Oxford BioDynamics (OBD) Competitors GBX 1.15 -0.06 (-4.96%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsInsider Trades OBD vs. RLM, NSCI, OPTI, ONC, SNG, BVX, CIZ, IMM, GENF, and IXIShould you be buying Oxford BioDynamics stock or one of its competitors? The main competitors of Oxford BioDynamics include Realm Therapeutics (RLM), NetScientific (NSCI), OptiBiotix Health (OPTI), Oncimmune (ONC), Synairgen (SNG), BiVictriX Therapeutics (BVX), Cizzle Biotechnology (CIZ), ImmuPharma (IMM), Genflow Biosciences (GENF), and IXICO (IXI). These companies are all part of the "biotechnology" industry. Oxford BioDynamics vs. Realm Therapeutics NetScientific OptiBiotix Health Oncimmune Synairgen BiVictriX Therapeutics Cizzle Biotechnology ImmuPharma Genflow Biosciences IXICO Oxford BioDynamics (LON:OBD) and Realm Therapeutics (LON:RLM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership. Is OBD or RLM more profitable? Realm Therapeutics' return on equity of 0.00% beat Oxford BioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets Oxford BioDynamicsN/A -266.70% -56.23% Realm Therapeutics N/A N/A N/A Does the media prefer OBD or RLM? In the previous week, Oxford BioDynamics' average media sentiment score of 0.00 equaled Realm Therapeutics'average media sentiment score. Company Overall Sentiment Oxford BioDynamics Neutral Realm Therapeutics Neutral Does the MarketBeat Community believe in OBD or RLM? Realm Therapeutics received 89 more outperform votes than Oxford BioDynamics when rated by MarketBeat users. Likewise, 71.75% of users gave Realm Therapeutics an outperform vote while only 60.82% of users gave Oxford BioDynamics an outperform vote. CompanyUnderperformOutperformOxford BioDynamicsOutperform Votes10460.82% Underperform Votes6739.18% Realm TherapeuticsOutperform Votes19371.75% Underperform Votes7628.25% Do insiders and institutionals have more ownership in OBD or RLM? 44.3% of Oxford BioDynamics shares are held by institutional investors. 16.8% of Oxford BioDynamics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has higher valuation and earnings, OBD or RLM? Realm Therapeutics has higher revenue and earnings than Oxford BioDynamics. Oxford BioDynamics is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOxford BioDynamics£176K20.38-£11.11M-£0.06-19.17Realm Therapeutics£501.92K26.71N/A-£17.50-0.66 SummaryRealm Therapeutics beats Oxford BioDynamics on 7 of the 10 factors compared between the two stocks. Ad Desko DigitalCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! Get Oxford BioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBD vs. The Competition Export to ExcelMetricOxford BioDynamicsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£3.59M£138.87M£5.15B£1.51BDividend YieldN/A3.50%5.00%11.34%P/E Ratio-19.17305.47126.461,599.46Price / Sales20.3815,932.611,231.14217,856.05Price / Cash3.9812.2040.2335.42Price / Book1.157.096.942.92Net Income-£11.11M-£18.95M£119.54M£138.19M7 Day Performance-7.26%0.15%0.98%-0.40%1 Month Performance-17.74%6.58%-4.33%-0.79%1 Year Performance-96.33%28.47%31.20%105.28% Oxford BioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBDOxford BioDynamicsN/AGBX 1.15-5.0%N/A-96.7%£3.59M£176,000.00-19.1745Gap DownRLMRealm TherapeuticsN/AGBX 11.50flatN/A+0.0%£13.41M£501,919.00-0.66N/ANSCINetScientificN/AN/AN/AN/A£12.81M£1.45M-486.3626OPTIOptiBiotix HealthN/AGBX 12.25-5.8%N/A-55.5%£12.00M£1.26M-408.331ONCOncimmuneN/AGBX 15.15+0.3%N/A-32.4%£11.23M£1.21M-504.6752Positive NewsSNGSynairgenN/AGBX 4.63+0.9%N/A-23.1%£9.32M£79,000.00-146.6034Gap UpBVXBiVictriX TherapeuticsN/AN/AN/A-9.1%£8.25MN/A-250.0017Gap UpHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 1.90+11.8%N/A-9.5%£7.53M£25,000.00-183.004Gap UpIMMImmuPharmaN/AGBX 1.57-1.3%N/A-10.3%£6.54M£94,819.00-157.0013GENFGenflow BiosciencesN/AGBX 1.75flatN/A-0.6%£6.12MN/A-179.005Gap UpIXIIXICON/AGBX 12+4.3%N/A-14.3%£5.80M£6M-300.0089 Related Companies and Tools Related Companies RLM Competitors NSCI Competitors OPTI Competitors ONC Competitors SNG Competitors BVX Competitors CIZ Competitors IMM Competitors GENF Competitors IXI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:OBD) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
